penicillin v has been researched along with cefazolin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Arakawa, Y; Kato, H; Kimura, K; Kurokawa, H; Nagano, N; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lindmark, A; Nord, CE; Persson, I | 1 |
| Nakashima, E; Takanosu, K; Tamai, I; Terasaki, T; Tsuji, A | 1 |
| Miyamoto, E; Tsuji, A; Yamana, T | 1 |
| Fridrich, KL; Partnoy, BE; Zeitler, DL | 1 |
| Caiazzo, R; Chambon, JP; Vallet, B; Zerbib, P | 1 |
1 review(s) available for penicillin v and cefazolin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for penicillin v and cefazolin
| Article | Year |
|---|---|
Prospective analysis of antibiotic prophylaxis for orthognathic surgery.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefazolin; Female; Humans; Male; Middle Aged; Orthognathic Surgical Procedures; Osteotomy; Penicillin G; Penicillin V; Premedication; Prospective Studies; Surgical Wound Infection | 1994 |
11 other study(ies) available for penicillin v and cefazolin
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
Topics: Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Cefepime; Cefotaxime; Ceftizoxime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Microbial Sensitivity Tests; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Streptococcal Infections; Streptococcus agalactiae | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
Topics: Ampicillin; Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; beta-Lactamases; Cefaclor; Cefadroxil; Cefazolin; Cephalexin; Cephalosporins; Clostridium perfringens; Fusobacterium; Humans; Microbial Sensitivity Tests; Penicillin V | 1989 |
Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes. Evidence for a carrier-mediated transport system.
Topics: Animals; Binding, Competitive; Biological Transport, Active; Cefazolin; Cell Membrane; Cephalosporins; Energy Metabolism; In Vitro Techniques; Kinetics; Liver; Penicillin G; Penicillin V; Rats; Serum Albumin, Bovine | 1986 |
Effects of surfactants on the GI absorption of beta-lactam antibiotics in rats.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Gastric Mucosa; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Penicillin V; Rats; Rats, Inbred Strains; Surface-Active Agents; Time Factors | 1983 |
[Management of splenectomized patients].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Bacterial Vaccines; Cefazolin; Child; Humans; Infant; Injections, Intravenous; Laparoscopy; Laparotomy; Penicillin V; Postoperative Complications; Risk Factors; Spleen; Splenectomy; Splenosis; Time Factors; Transplantation, Autologous | 2003 |